Summit Therapeu ADR (SMMT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,079,586 | -860,414 | -628,621 | -62,913 | -221,315 |
| Depreciation Amortization | 146 | 104 | 62 | 25 | 89 |
| Accounts payable and accrued liabilities | 15,303 | 17,448 | 18,287 | 356 | 2,015 |
| Other Working Capital | 31,416 | 23,080 | 15,219 | -6,186 | 15,479 |
| Other Operating Activity | 709,791 | 598,790 | 467,141 | 7,550 | 61,626 |
| Operating Cash Flow | $-322,930 | $-220,992 | $-127,912 | $-61,168 | $-142,106 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -173,653 | 311,340 | 311,340 | 160,532 | -190,195 |
| PPE Investments | -657 | -493 | -422 | -422 | -139 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -15,007 |
| Investing Cash Flow | $-174,310 | $310,847 | $310,918 | $160,110 | $-205,341 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 617,533 | 43,712 | 9,899 | 7,677 | 481,227 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -100,000 |
| Financing Cash Flow | $617,533 | $43,712 | $9,899 | $7,677 | $381,227 |
| Exchange Rate Effect | 102 | 121 | 99 | 38 | -18 |
| Beginning Cash Position | 105,187 | 105,187 | 105,187 | 105,187 | 71,425 |
| End Cash Position | 225,582 | 238,875 | 298,191 | 211,844 | 105,187 |
| Net Cash Flow | $120,395 | $133,688 | $193,004 | $106,657 | $33,762 |
| Free Cash Flow | |||||
| Operating Cash Flow | -322,930 | -220,992 | -127,912 | -61,168 | -142,106 |
| Capital Expenditure | -657 | -493 | -422 | -422 | -139 |
| Free Cash Flow | -323,587 | -221,485 | -128,334 | -61,590 | -142,245 |